“Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape” (2026) Canadian Hematology Today, 5(1), pp. 24–35. doi:10.58931/cht.2026.5185.